本頁面由Tiger Trade Technology Pte. Ltd.提供服務

塞德斯醫療

24.63
-0.1800-0.73%
盤後24.630.00000.00%18:13 EST
成交量:36.29萬
成交額:898.18萬
市值:16.37億
市盈率:-7.28
高:25.24
開:24.69
低:24.46
收:24.81
52周最高:30.50
52周最低:14.40
股本:6,644.95萬
流通股本:5,320.67萬
量比:0.46
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-3.3819
每股收益(LYR):-2.4515
淨資產收益率:-32.44%
總資產收益率:-21.77%
市淨率:2.74
市盈率(LYR):-10.05

資料載入中...

公司資料

公司名字:
塞德斯醫療
交易所:
NASDAQ
成立時間:
- -
員工人數:
186
公司地址:
Perryville III Building,Suite 220,53 Frontage Road,Hampton,New Jersey,United States
郵編:
08827
電話:
傳真:
908 454 1911
簡介:
Celldex Therapeutics, Inc.在特拉華州註冊成立。該公司是一家生物製藥公司,致力於探索肥大細胞生物學的科學並開發治療性抗體,這些抗體具有參与人體免疫系統並直接影響關鍵途徑的能力,以改善患有嚴重炎症、過敏、自身免疫和其他破壞性疾病的患者的生活。該公司的候選藥物包括單克隆和雙特異性抗體,旨在解決現有治療方法不足的肥大細胞介導疾病。

董事

名稱
職位
Anthony S. Marucci
President and Chief Executive Officer, Director
Larry Ellberger
Chairman of the Board of Directors
Gerald McMahon
董事
Harry H. Penner, Jr.
董事
Herbert J. Conrad
董事
James J. Marino
董事
Karen L. Shoos
董事
Keith L. Brownlie
董事

股東

名稱
職位
Anthony S. Marucci
President and Chief Executive Officer, Director
Avery W. Catlin
Senior Vice President, Chief Financial Officer and Secretary
Elizabeth Crowley
Senior Vice President and Chief Product Development Officer
Richard Wright
Senior Vice President and Chief Commercial Officer
Ronald Pepin
Senior Vice President and Chief Business Officer
Theresa LaVallee
Senior Vice President, Regulatory and Precision Medicine
Thomas Davis
Executive Vice President and Chief Medical Officer
Tibor Keler
Executive Vice President and Chief Scientific Officer